Hikma Pharmaceuticals PLC (HKMPF)
24.50
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Hikma Pharmaceuticals Shareholders Equity (Quarterly): 2.198B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.198B |
| June 30, 2023 | 2.189B |
| June 30, 2023 | 2.189B |
| December 31, 2022 | 2.135B |
| June 30, 2022 | 2.176B |
| June 30, 2022 | 2.176B |
| December 31, 2021 | 2.453B |
| June 30, 2021 | 2.29B |
| June 30, 2021 | 2.29B |
| December 31, 2020 | 2.135B |
| June 30, 2020 | 1.89B |
| June 30, 2020 | 1.89B |
| December 31, 2019 | 2.117B |
| June 30, 2019 | 1.832B |
| June 30, 2019 | 1.832B |
| December 31, 2018 | 1.685B |
| June 30, 2018 | 1.529B |
| June 30, 2018 | 1.529B |
| December 31, 2017 | 1.514B |
| June 30, 2017 | 2.44B |
| June 30, 2017 | 2.44B |
| December 31, 2016 | 2.396B |
| June 30, 2016 | 2.385B |
| June 30, 2016 | 2.385B |
| December 31, 2015 | 1.337B |
| Date | Value |
|---|---|
| June 30, 2015 | 1.256B |
| June 30, 2015 | 1.256B |
| December 31, 2014 | 1.197B |
| June 30, 2014 | 1.149B |
| June 30, 2014 | 1.149B |
| December 31, 2013 | 1.017B |
| June 30, 2013 | 880.94M |
| June 30, 2013 | 880.94M |
| December 31, 2012 | 833.00M |
| June 30, 2012 | 774.80M |
| June 30, 2012 | 774.80M |
| December 31, 2011 | 776.58M |
| June 30, 2011 | 779.11M |
| December 31, 2010 | 743.92M |
| June 30, 2010 | 694.97M |
| December 31, 2009 | 675.89M |
| June 30, 2009 | 639.20M |
| December 31, 2008 | 603.21M |
| June 30, 2008 | 613.98M |
| December 31, 2007 | 418.48M |
| June 30, 2007 | 379.69M |
| December 31, 2006 | 345.07M |
| June 30, 2006 | 314.46M |
| December 31, 2005 | 283.88M |
| June 30, 2005 | 159.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.832B
Minimum
Jun 2019
2.453B
Maximum
Dec 2021
2.119B
Average
2.176B
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
| NuCana PLC | 18.96M |
| Autolus Therapeutics PLC | 111.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.68B |
| Total Liabilities (Quarterly) | 2.471B |
| Debt to Equity Ratio | 0.5118 |
| Current Ratio | 1.568 |
| Net Debt Paydown Yield | 2.27% |